US OptionsDetailed Quotes

ABBV250502C230000

Watchlist

0.04
0.000.00%

15min DelayClose May 2 16:00 ET

0.00High0.00Low

AbbVie Stock Discussion

Moomoo Breakfast US

Apr 20 16:31

Columns What to Expect in the Week Ahead (Tesla, Alphabet Earnings; Global Flash PMI Reports)

Earnings Preview
Earnings season will intensify in the coming week, with reports expected from over 120 S&P 500 companies, including the Magnificent Seven's $Alphabet-A (GOOGL.US)$ $Alphabet-C (GOOG.US)$ and $Tesla (TSLA.US)$.
Elon Musk's electric vehicle company Tesla, which reports results on Tuesday after the close, is in the spotlight partly due to the billionaire's close ties to Trump. Alphabet is set to report...

US eases self-driving regulations: Can Tesla ride the policy wave to soar?

AMC Forever

Apr 11 00:13

Time to Buyyyyy!!!

$AbbVie (ABBV.US)$
This company's major earnings and factories are all within US. This should be more solid than those like MRK or JNJ if Trump does do the drug tariffs

Movers and Shakers

Apr 9 20:20

Columns Today's Pre-Market Movers and Top Ratings | BTU, CALM, ABBV and More

Morning Movers
Gapping Up
$Peabody Energy (BTU.US)$ shares extended gains to 11.10% in pre-market trading after a 9.2% rise yesterday, following President Trump's executive orders aimed at reviving the U.S. coal industry. Trump plans to use the Defense Production Act to support coal mining and next-generation technologies, and instruct the DOJ to challenge regulations affecting coal jobs, aiming to enhance U.S. AI leadership by b...

Teddy123

Apr 8 14:17

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

$AbbVie (ABBV.US)$
What are the key efficacy results of RINVOQ (ABBV) in treating giant cell arteritis?
RINVOQ showed 46.4% sustained remission rate at week 52 vs 29.0% for placebo, with 34.3% disease flare rate vs 55.6% for placebo, and 37.1% sustained complete remission vs 16.1% for placebo.
How does RINVOQ reduce steroid dependency in GCA patients?
RINVOQ demonstrated...

Investing with moomoo

Apr 1 18:42

Columns The Whole World Is Waiting for Trump to Wield the Tariff Stick. Here's What You Need to Know

President Donald Trump is gearing up to unveil a significant new set of import tariffs, which he refers to as “Liberation Day,”scheduled to commence this Wednesday (or Tuesday evening). The forthcoming announcement is poised to significantly intensify Trump's ongoing trade conflicts globally, with detailed information expected to be disclosed shortly.
On Monday, Trump suggested that he would be “very kind...

Trade talks sizzle: Market's next move?

Teddy123

Mar 26 20:39

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025

$AbbVie (ABBV.US)$
AbbVie Unveils Breakthrough Cancer Pipeline: New Dual-Target Drug Shows Promise Against Resistant Tumors

MojoRisin

Mar 25 22:49

$AbbVie (ABBV.US)$ ay yi yi, thought there was good stuff in the pipeline. Gonna hold on, historically it is resilient

Bruski2023

Mar 25 22:24

$ABBV 250328 207.50C$ in at .95 quick flip

Mr Worldwide 世界仔

Mar 20 18:21

FUNDAMENTALLY + TECHNICALLY OVERPRICED

$AbbVie (ABBV.US)$ Time to short
p/e at 90, flat revenue since 2021, cash from operation trending down since 2023. dividend payout ratio of 263%. Management is cashing out!
Weekly chart at upper trend channel.
Dont take too long, son. Papa is waiting you at the bottom!

Teddy123

Mar 16 11:14

ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

$AbbVie (ABBV.US)$
Breakthrough: ELAHERE Ovarian Cancer Drug Cuts Death Risk by 32%, Doubles Response Rate

No comment yet